New appointment at Alexza Pharmaceuticals
This article was originally published in Scrip
Alexza Pharmaceuticals has promoted Mark Oki to vice-president of finance and controller. Mr Oki joined Alexza as controller and director in 2006 shortly following the California-based firm's $44 million IPO. Mr Oki previously worked for Pharmacyclics and Incyte Genomics.